Overcoming barriers to long-term graft survival
- PMID: 16567241
- DOI: 10.1053/j.ajkd.2005.12.044
Overcoming barriers to long-term graft survival
Abstract
Although short-term kidney graft survival has improved in recent years, the focus has shifted to the challenge of improving long-term graft survival. Acute rejection, chronic allograft nephropathy, and cardiovascular disease are associated with graft loss and patient death. Reducing the potential for such posttransplantation complications may improve long-term graft survival. In addition, gaining a better understanding of the role that various immunosuppressive therapies have in decreasing the risk for graft injury will help clinicians make better-informed decisions about appropriate treatment regimens for individual kidney transplant recipients.
Similar articles
-
Early acute rejection does not affect chronic allograft nephropathy and death censored graft failure.Transplant Proc. 2004 Dec;36(10):2993-6. doi: 10.1016/j.transproceed.2004.10.070. Transplant Proc. 2004. PMID: 15686679
-
Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.Transplantation. 2001 Jun 15;71(11 Suppl):SS5-9. Transplantation. 2001. PMID: 11583489 Review.
-
Conclusions from the symposium.Transplant Proc. 2010 Nov;42(9 Suppl):S47-8. doi: 10.1016/j.transproceed.2010.09.016. Transplant Proc. 2010. PMID: 21095453
-
Chronic allograft nephropathy.Curr Opin Nephrol Hypertens. 2008 Mar;17(2):149-55. doi: 10.1097/MNH.0b013e3282f4e514. Curr Opin Nephrol Hypertens. 2008. PMID: 18277147 Review.
-
Management of the kidney transplant recipient.Prim Care. 2008 Sep;35(3):433-50, v. doi: 10.1016/j.pop.2008.03.003. Prim Care. 2008. PMID: 18710663 Review.
Cited by
-
Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model.Proc Natl Acad Sci U S A. 2009 Dec 15;106(50):21276-81. doi: 10.1073/pnas.0903978106. Epub 2009 Nov 23. Proc Natl Acad Sci U S A. 2009. PMID: 19934037 Free PMC article.
-
Clinical Features, Treatment and Prognostic Factors of Post-Transplant Immunoglobulin A Nephropathy.Ann Transplant. 2018 Mar 9;23:166-175. doi: 10.12659/AOT.907167. Ann Transplant. 2018. PMID: 29519995 Free PMC article.
-
Impact of posttransplantation glomerulonephritis on long-term outcome of kidney transplants: single-center 20-year experience.World J Surg. 2012 Dec;36(12):2923-30. doi: 10.1007/s00268-012-1759-x. World J Surg. 2012. PMID: 22941236
-
Predictive value of procalcitonin in chronic allograft dysfunction in kidney transplant recipients.Exp Ther Med. 2019 Dec;18(6):4603-4608. doi: 10.3892/etm.2019.8113. Epub 2019 Oct 21. Exp Ther Med. 2019. PMID: 31777558 Free PMC article.
-
Influence of Donor's Renal Function on the Outcome of Living Kidney Transplantation: 10-Year Follow-up.Korean J Urol. 2012 Feb;53(2):126-30. doi: 10.4111/kju.2012.53.2.126. Epub 2012 Feb 20. Korean J Urol. 2012. PMID: 22379593 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical